Detalhe da pesquisa
1.
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.
Br J Haematol
; 197(1): 76-81, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34881427